广发纳斯达克生物科技人民币(001092)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2017-06-30 麦迪逊医药 0.37%
2017-06-30 Ultragenyx Pharmaceutical Inc 0.35%
2017-06-30 Ironwood Pharmaceuticals Inc-A 0.34%
2017-06-30 Ligand Pharmaceuticals Inc 0.34%
2017-06-30 Agios Pharmaceuticals Inc 0.33%
2017-06-30 远藤制药 0.33%
2017-06-30 GW Pharmaceuticals plc ADR 0.31%
2017-06-30 AveXis Inc 0.3%
2017-06-30 FibroGen Inc 0.3%
2017-06-30 Supernus Pharmaceuticals Inc 0.29%
2017-06-30 Loxo Oncology Inc 0.28%
2017-06-30 Theravance Biopharma Inc 0.28%
2017-06-30 Prothena Corp plc 0.27%
2017-06-30 Blueprint Medicines Corp 0.26%
2017-06-30 Horizon Therapeutics plc 0.26%
2017-06-30 Radius Health Inc 0.26%
2017-06-30 Aerie Pharmaceuticals Inc 0.25%
2017-06-30 Spark Therapeutics Inc 0.25%
2017-06-30 Pacira BioSciences Inc 0.25%
2017-06-30 Sarepta Therapeutics Inc 0.25%

投资模拟

公告&资料